nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—CYP1A2—type 2 diabetes mellitus	0.411	1	CbGaD
Oxtriphylline—SLC22A7—Glyburide—type 2 diabetes mellitus	0.118	0.457	CbGbCtD
Oxtriphylline—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0459	0.179	CbGbCtD
Oxtriphylline—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0362	0.141	CbGbCtD
Oxtriphylline—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0342	0.133	CbGbCtD
Oxtriphylline—CYP1A2—Losartan—type 2 diabetes mellitus	0.0233	0.0906	CbGbCtD
Oxtriphylline—PDE3B—brown adipose tissue—type 2 diabetes mellitus	0.0183	0.189	CbGeAlD
Oxtriphylline—PDE3A—penis—type 2 diabetes mellitus	0.0106	0.11	CbGeAlD
Oxtriphylline—ADORA1—nerve—type 2 diabetes mellitus	0.00476	0.0491	CbGeAlD
Oxtriphylline—PDE3B—islet of Langerhans—type 2 diabetes mellitus	0.00388	0.04	CbGeAlD
Oxtriphylline—PDE3B—cardiovascular system—type 2 diabetes mellitus	0.0028	0.0289	CbGeAlD
Oxtriphylline—PDE3B—pancreas—type 2 diabetes mellitus	0.00272	0.0281	CbGeAlD
Oxtriphylline—PDE3B—adipose tissue—type 2 diabetes mellitus	0.00247	0.0255	CbGeAlD
Oxtriphylline—HDAC2—islet of Langerhans—type 2 diabetes mellitus	0.00228	0.0235	CbGeAlD
Oxtriphylline—PDE4D—cortex of kidney—type 2 diabetes mellitus	0.00223	0.023	CbGeAlD
Oxtriphylline—PDE4D—adipose tissue—type 2 diabetes mellitus	0.00206	0.0213	CbGeAlD
Oxtriphylline—ADORA2B—adipose tissue—type 2 diabetes mellitus	0.00205	0.0211	CbGeAlD
Oxtriphylline—HDAC2—retina—type 2 diabetes mellitus	0.00195	0.0201	CbGeAlD
Oxtriphylline—ADORA2A—cardiovascular system—type 2 diabetes mellitus	0.00193	0.0199	CbGeAlD
Oxtriphylline—SLC22A7—kidney—type 2 diabetes mellitus	0.00187	0.0193	CbGeAlD
Oxtriphylline—HDAC2—nephron tubule—type 2 diabetes mellitus	0.00183	0.0189	CbGeAlD
Oxtriphylline—PDE4A—adipose tissue—type 2 diabetes mellitus	0.00183	0.0188	CbGeAlD
Oxtriphylline—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.00183	0.0188	CbGeAlD
Oxtriphylline—PDE3B—liver—type 2 diabetes mellitus	0.00173	0.0179	CbGeAlD
Oxtriphylline—PDE3A—cardiovascular system—type 2 diabetes mellitus	0.00171	0.0177	CbGeAlD
Oxtriphylline—PDE4B—islet of Langerhans—type 2 diabetes mellitus	0.00171	0.0176	CbGeAlD
Oxtriphylline—ADORA1—cardiovascular system—type 2 diabetes mellitus	0.00167	0.0172	CbGeAlD
Oxtriphylline—HDAC2—cardiovascular system—type 2 diabetes mellitus	0.00165	0.017	CbGeAlD
Oxtriphylline—ADORA1—kidney—type 2 diabetes mellitus	0.00163	0.0168	CbGeAlD
Oxtriphylline—HDAC2—kidney—type 2 diabetes mellitus	0.00161	0.0166	CbGeAlD
Oxtriphylline—HDAC2—pancreas—type 2 diabetes mellitus	0.0016	0.0165	CbGeAlD
Oxtriphylline—ADORA1—cortex of kidney—type 2 diabetes mellitus	0.00159	0.0164	CbGeAlD
Oxtriphylline—HDAC2—cortex of kidney—type 2 diabetes mellitus	0.00157	0.0162	CbGeAlD
Oxtriphylline—PDE3A—adipose tissue—type 2 diabetes mellitus	0.00151	0.0156	CbGeAlD
Oxtriphylline—ADORA1—adipose tissue—type 2 diabetes mellitus	0.00147	0.0152	CbGeAlD
Oxtriphylline—HDAC2—adipose tissue—type 2 diabetes mellitus	0.00145	0.015	CbGeAlD
Oxtriphylline—PDE4D—liver—type 2 diabetes mellitus	0.00145	0.0149	CbGeAlD
Oxtriphylline—PDE4B—pancreas—type 2 diabetes mellitus	0.0012	0.0124	CbGeAlD
Oxtriphylline—ADORA2A—liver—type 2 diabetes mellitus	0.0012	0.0123	CbGeAlD
Oxtriphylline—SLC22A7—liver—type 2 diabetes mellitus	0.00118	0.0122	CbGeAlD
Oxtriphylline—PDE4B—cortex of kidney—type 2 diabetes mellitus	0.00118	0.0121	CbGeAlD
Oxtriphylline—PDE4B—adipose tissue—type 2 diabetes mellitus	0.00109	0.0112	CbGeAlD
Oxtriphylline—PDE3A—liver—type 2 diabetes mellitus	0.00106	0.0109	CbGeAlD
Oxtriphylline—HDAC2—liver—type 2 diabetes mellitus	0.00102	0.0105	CbGeAlD
Oxtriphylline—Theophylline—CYP2E1—type 2 diabetes mellitus	0.000816	0.196	CrCbGaD
Oxtriphylline—Caffeine—CYP2E1—type 2 diabetes mellitus	0.000801	0.192	CrCbGaD
Oxtriphylline—Theophylline—CYP1A2—type 2 diabetes mellitus	0.000776	0.186	CrCbGaD
Oxtriphylline—PDE4B—liver—type 2 diabetes mellitus	0.000763	0.00787	CbGeAlD
Oxtriphylline—Caffeine—CYP1A2—type 2 diabetes mellitus	0.000762	0.183	CrCbGaD
Oxtriphylline—Theophylline—CYP3A4—type 2 diabetes mellitus	0.000514	0.123	CrCbGaD
Oxtriphylline—Caffeine—CYP3A4—type 2 diabetes mellitus	0.000505	0.121	CrCbGaD
Oxtriphylline—CYP1A2—liver—type 2 diabetes mellitus	0.000469	0.00483	CbGeAlD
Oxtriphylline—PDE4C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-05	5.65e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.3e-05	5.64e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.3e-05	5.64e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.29e-05	5.62e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.29e-05	5.61e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.29e-05	5.6e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.28e-05	5.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.28e-05	5.57e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.28e-05	5.57e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.28e-05	5.56e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—type 2 diabetes mellitus	1.28e-05	5.55e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.28e-05	5.55e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.27e-05	5.49e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.26e-05	5.47e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.26e-05	5.47e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.25e-05	5.45e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.25e-05	5.45e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—RELA—type 2 diabetes mellitus	1.24e-05	5.4e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.24e-05	5.4e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.24e-05	5.39e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.24e-05	5.38e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.23e-05	5.36e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.23e-05	5.35e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.22e-05	5.32e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.22e-05	5.32e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.22e-05	5.3e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.22e-05	5.29e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.22e-05	5.29e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.21e-05	5.27e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.21e-05	5.27e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.21e-05	5.25e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.21e-05	5.25e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.21e-05	5.24e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.2e-05	5.21e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.19e-05	5.16e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.19e-05	5.15e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.19e-05	5.15e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.18e-05	5.14e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-05	5.13e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-05	5.12e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-05	5.12e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.18e-05	5.11e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.17e-05	5.08e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.17e-05	5.07e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.17e-05	5.07e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.17e-05	5.07e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.17e-05	5.06e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.16e-05	5.06e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.16e-05	5.06e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.15e-05	5e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.15e-05	5e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.15e-05	4.97e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.14e-05	4.96e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.13e-05	4.92e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.13e-05	4.92e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.13e-05	4.91e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-05	4.88e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.12e-05	4.87e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—INS—type 2 diabetes mellitus	1.12e-05	4.85e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.12e-05	4.84e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.11e-05	4.83e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-05	4.82e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.1e-05	4.78e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.1e-05	4.77e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.1e-05	4.76e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.1e-05	4.76e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-05	4.75e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.08e-05	4.71e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.08e-05	4.69e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.08e-05	4.69e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.08e-05	4.68e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.08e-05	4.68e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-05	4.68e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.08e-05	4.68e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.07e-05	4.64e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-05	4.63e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.06e-05	4.61e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.06e-05	4.61e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.05e-05	4.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.05e-05	4.56e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.05e-05	4.56e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-05	4.54e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.04e-05	4.51e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.04e-05	4.51e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—SRC—type 2 diabetes mellitus	1.03e-05	4.49e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.03e-05	4.48e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.03e-05	4.47e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.03e-05	4.46e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.03e-05	4.46e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.03e-05	4.45e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.03e-05	4.45e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.02e-05	4.43e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-05	4.39e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.01e-05	4.38e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-05	4.36e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1e-05	4.36e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1e-05	4.36e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1e-05	4.34e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.99e-06	4.34e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.99e-06	4.34e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.99e-06	4.34e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.98e-06	4.33e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SRC—type 2 diabetes mellitus	9.94e-06	4.32e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.94e-06	4.32e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	9.92e-06	4.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	9.92e-06	4.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	9.92e-06	4.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	9.92e-06	4.31e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.89e-06	4.29e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.85e-06	4.28e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.82e-06	4.27e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.82e-06	4.27e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.79e-06	4.25e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.79e-06	4.25e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.79e-06	4.25e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SRC—type 2 diabetes mellitus	9.78e-06	4.25e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.72e-06	4.22e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.68e-06	4.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.54e-06	4.14e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.53e-06	4.14e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.53e-06	4.14e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.53e-06	4.14e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	9.51e-06	4.13e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.46e-06	4.11e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.35e-06	4.06e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.34e-06	4.06e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.31e-06	4.04e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.24e-06	4.01e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TGFB1—type 2 diabetes mellitus	9.24e-06	4.01e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.24e-06	4.01e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.21e-06	4e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.17e-06	3.98e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.16e-06	3.98e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.1e-06	3.95e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.1e-06	3.95e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.07e-06	3.94e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EGFR—type 2 diabetes mellitus	9.06e-06	3.94e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.06e-06	3.94e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.06e-06	3.93e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.05e-06	3.93e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.99e-06	3.9e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.95e-06	3.89e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.89e-06	3.86e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	8.84e-06	3.84e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.82e-06	3.83e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.74e-06	3.8e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.72e-06	3.79e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.71e-06	3.78e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.61e-06	3.74e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.57e-06	3.72e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	8.56e-06	3.72e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.49e-06	3.69e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.39e-06	3.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.32e-06	3.61e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.31e-06	3.61e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	8.25e-06	3.58e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.16e-06	3.54e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.1e-06	3.52e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	8.09e-06	3.51e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	8.09e-06	3.51e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.94e-06	3.45e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	7.93e-06	3.44e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.88e-06	3.42e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	7.88e-06	3.42e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	7.88e-06	3.42e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	7.88e-06	3.42e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.85e-06	3.41e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	7.83e-06	3.4e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.8e-06	3.39e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.79e-06	3.38e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.77e-06	3.37e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.72e-06	3.35e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.7e-06	3.34e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	7.69e-06	3.34e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.67e-06	3.33e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.64e-06	3.32e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	7.6e-06	3.3e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.57e-06	3.29e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.55e-06	3.28e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.3e-06	3.17e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.24e-06	3.14e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.22e-06	3.14e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.09e-06	3.08e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.08e-06	3.07e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.07e-06	3.07e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.07e-06	3.07e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.07e-06	3.07e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.05e-06	3.06e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.98e-06	3.03e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—type 2 diabetes mellitus	6.96e-06	3.02e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.94e-06	3.01e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—AKT1—type 2 diabetes mellitus	6.92e-06	3e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.91e-06	3e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.88e-06	2.99e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.78e-06	2.94e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.73e-06	2.92e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.73e-06	2.92e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.7e-06	2.91e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—type 2 diabetes mellitus	6.59e-06	2.86e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.56e-06	2.85e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.47e-06	2.81e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	6.47e-06	2.81e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKT1—type 2 diabetes mellitus	6.42e-06	2.79e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.39e-06	2.78e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.37e-06	2.77e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.35e-06	2.76e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.27e-06	2.72e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.23e-06	2.71e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.2e-06	2.69e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.18e-06	2.68e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.13e-06	2.66e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.13e-06	2.66e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.1e-06	2.65e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.08e-06	2.64e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.02e-06	2.61e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.9e-06	2.56e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.87e-06	2.55e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.8e-06	2.52e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.79e-06	2.51e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.63e-06	2.44e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.42e-06	2.35e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.35e-06	2.32e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.28e-06	2.29e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.28e-06	2.29e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.26e-06	2.28e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.19e-06	2.25e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.04e-06	2.19e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.9e-06	2.13e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.88e-06	2.12e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.81e-06	2.09e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.71e-06	2.04e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.69e-06	2.04e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.57e-06	1.98e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.53e-06	1.97e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.51e-06	1.96e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.5e-06	1.95e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.33e-06	1.88e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.25e-06	1.84e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.18e-06	1.82e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.11e-06	1.79e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.05e-06	1.76e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.03e-06	1.75e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.99e-06	1.73e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.51e-06	1.52e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.44e-06	1.5e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.16e-06	1.37e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.02e-06	1.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.02e-06	1.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.76e-06	1.2e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.39e-06	6.03e-06	CbGpPWpGaD
